Healthy cells can efficiently use ketones for energy. Cancer cells, with their broken mitochondria, cannot. This creates a powerful therapeutic opportunity: a ketogenic state can nourish the body's healthy cells while simultaneously starving tumor cells of their required fuel.

Experiments show that transferring a cancer cell's dysfunctional mitochondria—but not its nucleus—into a healthy cell is what induces cancer. This disruptive finding supports the view of cancer as a metabolic disease that can be targeted by starving its mitochondria of fuels like glucose.

Many cancer cells rely heavily on glucose (the Warburg effect) and cannot efficiently use ketones. A strict ketogenic diet may starve these tumors while nourishing healthy cells. In one case, it led to a 70% reduction in cancer markers in six weeks, far exceeding chemotherapy's expected 30%.

Beyond being an alternative fuel source, the ketone body beta-hydroxybutyrate (BHB) functions as a signaling molecule. It acts as an HDAC inhibitor, which can activate genes that enhance the body's antioxidant and cellular defense mechanisms, a pathway of interest in cancer therapy.

A dual-payload strategy attacks cancer on two fronts. One payload induces localized tumor damage via chemotherapy. The second simultaneously supplies a key immune signal (interferon beta) that aggressive tumors suppress, converting the damage into a robust, recognizable anti-tumor immune response.

Traditional targeted cancer therapies inhibit or 'cool down' overactive pathways, like pumping brakes on a runaway car. Delpha Therapeutics employs a counterintuitive 'activation lethality' approach, further over-activating pathways to 'overheat the engine' and cause catastrophic failure in cancer cells—a fundamentally opposite but highly effective strategy.

In a randomized controlled trial for stage 4 metastatic pancreatic cancer, adding Virta Health's nutritional therapy to a three-drug chemo regimen resulted in a ~35% life extension. This suggests improving metabolic health can significantly impact outcomes even in aggressive cancers.

In a ketogenic state, healthy cells enter a protective "bunker mode," slowing division. Cancer cells lack this evolutionary off-switch and remain exposed. This synergy makes tumors more vulnerable to chemotherapy, allowing for lower, less toxic doses with greater effect.

The origin of cancer is damage to the mitochondria, the cell's powerhouses. This impairs energy production, forcing cells into a primitive state of uncontrolled growth. Genetic mutations are a downstream effect, not the primary cause.